Nocturnal oxygen therapy as an option for early COVID-19
There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:98 |
|---|---|
| Enthalten in: |
International Journal of Infectious Diseases - 98(2020), Seite 176-179 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chongxing Shen [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| doi: |
10.1016/j.ijid.2020.06.080 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ003978850 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ003978850 | ||
| 003 | DE-627 | ||
| 005 | 20230502073724.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2020.06.080 |2 doi | |
| 035 | |a (DE-627)DOAJ003978850 | ||
| 035 | |a (DE-599)DOAJef6315c6e8a34424932e2e5412568f68 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Chongxing Shen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nocturnal oxygen therapy as an option for early COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability. | ||
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Nocturnal oxygen therapy | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Immunomodulation | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a Xiaofeng Yue |e verfasserin |4 aut | |
| 700 | 0 | |a Jianwu Wang |e verfasserin |4 aut | |
| 700 | 0 | |a Chunmeng Shi |e verfasserin |4 aut | |
| 700 | 0 | |a Weibing Li |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t International Journal of Infectious Diseases |d Elsevier, 2015 |g 98(2020), Seite 176-179 |w (DE-627)DOAJ000043923 |x 18783511 |7 nnns |
| 773 | 1 | 8 | |g volume:98 |g year:2020 |g pages:176-179 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijid.2020.06.080 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/ef6315c6e8a34424932e2e5412568f68 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1201971220305154 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1201-9712 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 98 |j 2020 |h 176-179 | ||